ADDvise acquires CliniChain Holding B.V.
ADDvise Group AB has today entered into a share purchase agreement with the owners of CliniChain Holding B.V. (“CliniChain”) regarding the acquisition of all the outstanding shares of CliniChain in accordance with the letter of intent communicated via a press release dated September 6, 2022. Closing of the acquisition takes place no later than December 16, 2022. CliniChain wins order worth EUR 12.8 million CliniChain’s revenue for the last twelve months per October 31, 2022 amounted to approximately EUR 7.4 million, with an adjusted EBITDA of approximately EUR 4.0 million,